RedHill Biopharma to Present at the Jefferies Microbiome Summit
Dec 05, 2016 13:01 pm UTC| Business
TEL-AVIV, Israel, Dec. 05, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...
FRONTEO Completes Beta Version of its Prediction of Patient Fall System
Dec 05, 2016 13:01 pm UTC| Business
Yielding more accurate prediction than current international standards for determining risk of falling Further clinical trials underway, aiming to make the system operational in medical facilities within fiscal 2016 ...
FRONTEO Completes Beta Version of its Prediction of Patient Fall System
Dec 05, 2016 13:01 pm UTC| Business
Yielding more accurate prediction than current international standards for determining risk of falling Further clinical trials underway, aiming to make the system operational in medical facilities within fiscal 2016 ...
Dec 05, 2016 13:01 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Dec. 05, 2016 -- Immune Design, a clinical-stage immunotherapy company focused on oncology, today announced new data that highlight the broad product reach potential of both its...
Dec 05, 2016 13:01 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Dec. 05, 2016 -- Immune Design, a clinical-stage immunotherapy company focused on oncology, today announced new data that highlight the broad product reach potential of both its...
Dec 05, 2016 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced the...
Dec 05, 2016 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced the...